methamphetamine has been researched along with minocycline in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Miller, DB; O'Callaghan, JP; Sriram, K | 2 |
| Fukumoto, D; Hashimoto, K; Iyo, M; Kakiuchi, T; Nishiyama, S; Tsukada, H | 1 |
| Fujimoto, Y; Hashimoto, K; Iyo, M; Kitaichi, K; Nakayama, H; Shimizu, E; Zhang, L | 1 |
| Fukakusa, A; Ibi, D; Ito, Y; Kim, HC; Mizoguchi, H; Nakatani, A; Takuma, K; Yamada, K | 1 |
| Hashimoto, K | 1 |
| Boger, HA; Granholm, AC; McGinty, JF; Middaugh, LD | 1 |
| Fujita, Y; Hashimoto, K; Iyo, M; Kunitachi, S | 1 |
| Beardsley, PM; Hendrick, ES; Snider, SE | 1 |
| Fujita, Y; Hashimoto, K; Ishima, T; Zhang, L | 1 |
| Arezoomandan, R; Attarzadeh-Yazdi, G; Haghparast, A | 1 |
| Bayani Ershadi, AS; Dastvar, S; Ghavimi, H; Hosseini, MJ | 1 |
3 review(s) available for methamphetamine and minocycline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Minocycline as a therapeutic drug for methamphetamine use disorders].
Topics: Animals; Anti-Bacterial Agents; Brain; Disease Models, Animal; Humans; Methamphetamine; Minocycline; N-Methyl-3,4-methylenedioxyamphetamine; Positron-Emission Tomography; Psychoses, Substance-Induced; Schizophrenia; Substance-Related Disorders | 2008 |
[Antibiotic drug minocycline: a potential therapeutic drug for methamphetamine-related disorders].
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Humans; Methamphetamine; Minocycline; Schizophrenia; Substance-Related Disorders | 2013 |
13 other study(ies) available for methamphetamine and minocycline
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Cell Count; Chemokine CCL2; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Glial Fibrillary Acidic Protein; Homovanillic Acid; Interleukin-6; Male; Methamphetamine; Mice; Mice, Mutant Strains; Microglia; Minocycline; Neurons; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Tyrosine 3-Monooxygenase | 2006 |
Protective effects of minocycline on the reduction of dopamine transporters in the striatum after administration of methamphetamine: a positron emission tomography study in conscious monkeys.
Topics: Animals; Brain Mapping; Consciousness; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Macaca mulatta; Male; Methamphetamine; Minocycline; Neuroprotective Agents; Positron-Emission Tomography; Time Factors | 2007 |
Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.
Topics: Animals; Disease Models, Animal; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Minocycline; Motor Activity; Movement; Substance-Related Disorders | 2006 |
Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice.
Topics: Animals; Behavior, Animal; Clozapine; Dose-Response Relationship, Drug; Exploratory Behavior; Haloperidol; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Memory Disorders; Methamphetamine; Mice; Mice, Inbred ICR; Minocycline; Mitogen-Activated Protein Kinase 3; Motor Activity; Neuroprotective Agents; Phosphorylation; Time Factors | 2008 |
Defining "neuroinflammation".
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Bacterial Agents; Antibodies, Phospho-Specific; Brain; Chemokines; Cytokines; Dopamine; Glial Fibrillary Acidic Protein; Gliosis; Humans; Inflammation; Methamphetamine; Mice; Mice, Inbred C57BL; Minocycline; Neurotoxins; NF-kappa B; Receptors, Tumor Necrosis Factor; Signal Transduction; Tyrosine 3-Monooxygenase | 2008 |
Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice.
Topics: Analysis of Variance; Animals; Body Temperature; Cell Count; Corpus Striatum; Glial Cell Line-Derived Neurotrophic Factor; Heterozygote; Immunohistochemistry; Methamphetamine; Mice; Mice, Transgenic; Microglia; Minocycline; Motor Activity; Neurons; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Photomicrography; Substantia Nigra; Tyrosine 3-Monooxygenase | 2009 |
The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice.
Topics: Animals; Anti-Bacterial Agents; Conditioning, Psychological; Dopamine; Methamphetamine; Mice; Mice, Inbred C57BL; Minocycline; Reward | 2012 |
Glial cell modulators attenuate methamphetamine self-administration in the rat.
Topics: Animals; Behavior, Animal; Male; Methamphetamine; Minocycline; Neuroglia; Pyridines; Rats; Self Administration; Substance-Related Disorders | 2013 |
Minocycline, an antibiotic with inhibitory effect on microglial activation, attenuates the maintenance and reinstatement of methamphetamine-seeking behavior in rat.
Topics: Animals; Anti-Bacterial Agents; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Male; Methamphetamine; Minocycline; Rats; Rats, Wistar; Reinforcement, Psychology; Substance-Related Disorders | 2014 |
The effects of minocycline in improving of methamphetamine withdrawal syndrome in male mice.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Male; Methamphetamine; Mice; Minocycline; Substance Withdrawal Syndrome | 2022 |